The company's multi-year strategy involves the rollout of new products and upgrades to existing ones that further strengthen its position.

The Broad Institute gene-sequencing lab used Roche equipment to read infants’ DNA genomes in less than four hours, cutting an ...

The company shared pilot data about its Constellation tech and released 5-Base, a product for jointly analyzing genetic and epigenetic data.

Biotech company 10x Genomics filed two lawsuits against rival Illumina in Delaware federal court on Tuesday, accusing ...

Illumina is rated a BUY as it drives growth with AI, multiomics, and strategic acquisitions. Click here to read my earnings ...

Unlike conventional methylation conversion technologies, Illumina's proprietary conversion chemistry selectively converts methylated cytosine to thymine. This selective conversion of methylated ...

Illumina launches BioInsight, a new business to accelerate technology and data-driven discovery: San Diego Saturday, October 4, 2025, 14:00 Hrs [IST] Illumina, Inc., a global geno ...

Illumina aims to transform human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related consumables to help ...

Illumina (ILMN) just launched BioInsight, a new business unit focused on combining sequencing, software, and AI for advanced biological insights. Executive changes and this expansion highlight the ...

Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx .

US-based company is developing next-generation sequencers, using AI models in the Republic to speed up diagnostics and lower ...